FSV.TO 0.19TOU.TO 1.28BN.TO -0.16PRM.TO 0.05RIT.TO 0.11ZGI.TO 1.44DDOG 1.44SIEGY 0
Baxter International Inc (BAX)

NYSE:BAX

Baxter International Inc (BAX)

22.86
+0.28 (1.24%)
as of Jul 7, 2026, 8:00:00 pm Market Open.
11 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
TOP PICK

Baxter International Inc(BAX)

Oct 15, 2009
Global healthcare. Products tend to target blood and circulatory problems. Most of their products tend to be used in critical/chronic care situations so not affected by the economy. About 60% of earnings come from outside the US. Think they have a strong pipeline going forward.
Photo of Christine PooleChristine Poole
Owned
Unlock Rating
$54.50

Stock price when the opinion was issued

$22.86

As of Jul 07, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Baxter International Inc(BAX)

Oct 15, 2009
Global healthcare. Products tend to target blood and circulatory problems. Most of their products tend to be used in critical/chronic care situations so not affected by the economy. About 60% of earnings come from outside the US. Think they have a strong pipeline going forward.
Photo of Christine PooleChristine Poole
Owned
Unlock Rating
$54.50

Stock price when the opinion was issued

$22.86

As of Jul 07, 2026. Market Open.

biotechnologypharmaceutical
HOLD

Baxter International Inc(BAX)

Sep 03, 2008
(Almost chose this is a Top Pick.) Has just gone into new all-time highs. Above the 200 day moving average. On any pullback towards $65 you could buy more.
Photo of Ron MeiselsRon MeiselsUnlock Rating
$69.70

Stock price when the opinion was issued

$22.86

As of Jul 07, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Baxter International Inc(BAX)

Aug 21, 2008
This group has been out of favour since 2000. This one has an above average growth rate against its peers. Have 3 core areas and all 3 are doing very well. Margins are expanding. Estimates are rising. International exposure.
Photo of David BurrowsDavid Burrows
Owned
Unlock Rating
$70.03

Stock price when the opinion was issued

$22.86

As of Jul 07, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Baxter International Inc(BAX)

Aug 31, 2006
Recently bought a company, so there are some funky things going on with their balance sheet. His model price is $32.43, a negative 27% differential. A lot of people are buying these companies because of fear of an economic slowdown.
Photo of Brian Acker, CABrian Acker, CA
No
Unlock Rating
$44.38

Stock price when the opinion was issued

$22.86

As of Jul 07, 2026. Market Open.

biotechnologypharmaceutical
Showing 31 to 35 of 35 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

NOW 2.8$110.73
TD.TO 1.04$172.36
CSU.TO 90.89$2847.95
CCL.B.TO -0.23$92
QSR.TO 0.86$104.96

Today's Top Picks

FSV.TO 0.19$205.65
TOU.TO 1.28$60.28
BN.TO -0.16$62.28
PRM.TO 0.05$14.31
RIT.TO 0.11$18.68

Popular Articles

Latest Sell Signals

SLF.TO 1.2$113.46
SOXX -29.82$551.69
GS -12.31$1042.98
RCI.B.TO 1.41$46.15
CCA.TO 0.36$63.87

Most Recent Experts

Ernest Wong, Head of Research, Baskin Wealth Management

Ernest Wong, Head of Research, Baskin Wealth Management

Baskin Wealth Management

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Kim Bolton

Kim Bolton

Black Swan Dexteritas

Larry Berman CFA, CMT, CTA

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica
The ultimate 360° Tracker Your financial life in one place, automatically

You may also like